You searched for "AMD"
Specialty-driven EMR for paperless clinical environment – insights for an informed choice
1 August 2016
| Rod McNeil
|
EYE - General
Deployment of specialty-driven (or specialty-specific) electronic medical record (EMR) systems across UK ophthalmology units appears to be growing rapidly at the expense of generic, multiuse digital technology packages. Experience further suggests that open source systems can play a significant role...
Post hoc analysis of the CANTREAT randomised trial
1 December 2023
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Age-related macular degeneration, Randomized clinical trial, Ranibizumab, Treat-and-extend
CANTREAT, a Canadian multicentre two-year randomised trial compares treat and extend treatment (T&E) relative to the monthly administration of Ranibizumab in nAMD. Two-hundred and eighty-five treatment-naïve patients with nAMD were randomised to receive either a once-monthly dosing or T&E regimen...
Sharing best practice and landmark evidence in glaucoma care
Evolving technology, best practice and landmark evidence in glaucoma care were reviewed by an international expert faculty in session presentations and debates during the 11th Moorfields International Glaucoma Symposium 2019. The authors were meeting chairs and provide an overview of...What's trending Apr/May 2022
5 April 2022
| Stephanie Chiu
|
EYE - General
A round-up of the eye-related hot topics that have been trending over the last few weeks. #ArgusI #ArgusII #bioniceye #retinitispigmentosa #SecondSight Remember Argus I & Argus II? Its star burned bright, touted as the future of treatment for retinitis pigmentosa....
RPE tears after intravitreal Lucentis
1 February 2017
| Saruban Pasu
|
EYE - Vitreo-Retinal
The current hypothesis regarding retinal pigment epithelium (RPE) tears is the contraction and fibrosis in choroidal neovascularisation (CNV) tissue after anti-VEGF therapy can induce rips in the overlying RPE. This South Korean study aimed to identify the association between RPE...
New survey reveals over half of UK adults expect to experience sight loss in the next 10 years.
This survey and media article are fully organised and funded by Apellis. New survey reveals over half of UK adults expect to experience sight loss in the next 10 years. Yet more than one in four (29%) of those surveyed...Sight Scotland and Sight Scotland Veterans appoint Paul Bott as new Chair of the Board
Sight Scotland and Sight Scotland Veterans are delighted to announce the appointment of Paul Bott as the new Chair of the Board.Beyond 2020: An educational video series from the Amazonian rainforest
It has been estimated that one billion people globally live with visual impairment. Moreover, countries in the developing world are disproportionately affected, with four times more low vision than compared to countries with well-established systems of primary, secondary and tertiary...Preview: Oxford Ophthalmological Congress
18 June 2024
| Samuel Verdin
|
conferences, events, Oxford, OOC, registration, opportunities, education, meeting, England, UK
Between 1–3 July, we will be heading down to England for the 107th Oxford Ophthalmological Congress.
Serendipity
3 October 2024
| Peter Cackett
“Serendipity is looking in a haystack for a needle and discovering a farmer’s daughter” – Julius Comroe Jr (Surgeon, Medical Researcher and Author) One of the attractive features of ophthalmology, apart from the good quality of life and the relatively...
Could Twitter boost the impact of ophthalmic journal articles?
1 October 2021
| Murad Khan, Karishma Parmar, Sohaib Rufai
|
EYE - General
*Equally contributing co-first authors. The authors investigate the link between ‘tweets’ and citations for 155 articles from five key ophthalmology journals. Social media’s impact on our lives has been significant, allowing easy discussion of topics worldwide. An increasing number of...
Learnings and trends in the management of open-angle and angle-closure glaucoma
1 August 2017
| Winifred Nolan, Nick Strouthidis, Keith Barton
|
EYE - Glaucoma
To be truly disruptive, newer technologies need to offer a quality of life benefit over medication to a broad population of glaucoma sufferers. Evidence and converging trends in medical and surgical management of glaucoma were explored in counterpoint discussions and...
